A Study to Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects on Relative Absorption Healthy Participants

Lead Sponsor

Bristol-Myers Squibb

Age

18 - 55 years

Sex

ALL

Healthy Volunteers

Yes

•Women not of childbearing potential and men, ages 18 or local age of majority to 55 years, inclusive
•Healthy male and female non-Japanese participants without clinically significant deviation from normal in medical history, physical examination, electrocardiogram (ECG), and clinical laboratory determinations
•Body mass index (BMI) of 18 to 32 kg/m2, inclusive, and total body weight ≥ 50 kg

•Known or suspected autoimmune disorder, including but not limited to rheumatoid arthritis, fibromyalgia, systemic lupus erythematosus, polymyalgia rheumatica, giant cell arteritis, Behcet's disease, dermatomyositis, MS, moderate to severe asthma, any autoimmune vasculitis, autoimmune hepatitis, or any other active autoimmune disease for which a participant requires medical follow-up or medical treatment
•Any history of known or suspected congenital or acquired immunodeficiency state or condition that would compromise the participant's immune status
•Presence of any factors that would predispose the participant to develop infection
•A history of bacterial or fungal meningitis within 1 year prior to screening
•A history of intracranial or intraspinal bleeding
•Known intracranial space-occupying mass, including meningioma

Related studies

NCT06342713 · Healthy Participants, Healthy Subjects, and more

NCT07310901 · Obese But Otherwise Healthy Participants

NCT07471204 · Osteoarthritis of Knee, Healthy Participants

NCT07401472 · Healthy Participants Study

NCT07412353 · Healthy Participants